Literature DB >> 31625041

A Systems-Level Approach to Improving Medication Adherence in Hypertensive Latinos: a Randomized Control Trial.

Antoinette Schoenthaler1, Franzenith de la Calle2, Maria Pitaro3, Audrey Lum3, William Chaplin4, Jazmin Mogavero4, Milagros C Rosal5.   

Abstract

BACKGROUND: Despite numerous interventions targeting medication adherence in patients with uncontrolled hypertension, practice-based trials in Latino patients are scant.
OBJECTIVE: To evaluate the effect of a systems-level adherence intervention, delivered by medical assistants (MAs), versus a comparison condition on medication adherence and blood pressure (BP) in 119 hypertensive Latino patients who were initially non-adherent to their antihypertensive medications. STUDY
DESIGN: Randomized control trial. PARTICIPANTS: Patients (50% women; mean age, 61 years) were recruited from April 2013 to August 2015 in a community-based practice in New York. INTERVENTION: Systems-level approach that included an office system component built into the electronic health record and a provider support component consisting of nine MA-delivered health coaching sessions for improving medication adherence. The comparison group received the standard health coaching procedures followed at the clinic. MAIN OUTCOME MEASURES: The primary outcome was rate of medication adherence measured by an electronic monitoring device (EMD) across 6 months. The secondary outcomes were self-reported medication adherence measured by the eight-item Morisky Medication Adherence Scale (MMAS-8) and BP reduction from baseline to 6 months. KEY
RESULTS: Adherence as measure by EMD worsened for both groups (p = 0.04) with no between-group difference (- 9.6% intervention and - 6.6% control, p = 0.66). While systolic BP improved in both groups, the difference between groups was not significant (- 6 mmHg in intervention vs. - 2.7 mmHg in control, p = 0.34). In contrast, the intervention group had a greater improvement in self-reported adherence (mean change 1.98 vs. 1.26, p = 0.03) when measured using the MMAS-8.
CONCLUSIONS: Among Latinos with poorly controlled BP who were non-adherent to their antihypertensive medications, a systems-level intervention did not improve adherence as measured by EMD nor blood pressure. However, many patients reported challenges to using the EMD. Improvements in self-reported adherence suggest that this measure captures different aspects of adherence behavior than EMD. CLINICAL TRIAL REGISTRATION: NCT03560596.

Entities:  

Keywords:  Latino; hypertension; medication adherence; team care

Mesh:

Substances:

Year:  2019        PMID: 31625041      PMCID: PMC6957668          DOI: 10.1007/s11606-019-05419-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  43 in total

1.  The teamlet model of primary care.

Authors:  Thomas Bodenheimer; Brian Yoshio Laing
Journal:  Ann Fam Med       Date:  2007 Sep-Oct       Impact factor: 5.166

2.  Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study.

Authors:  B Waeber; G Leonetti; R Kolloch; G T McInnes
Journal:  J Hypertens       Date:  1999-07       Impact factor: 4.844

3.  Effect of treatment and adherence on ethnic differences in blood pressure control among adults with hypertension.

Authors:  Sundar Natarajan; Elizabeth J Santa Ana; Youlian Liao; Stuart R Lipsitz; Daniel L McGee
Journal:  Ann Epidemiol       Date:  2009-03       Impact factor: 3.797

4.  Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter?

Authors:  Ana H Traylor; Julie A Schmittdiel; Connie S Uratsu; Carol M Mangione; Usha Subramanian
Journal:  J Gen Intern Med       Date:  2010-06-23       Impact factor: 5.128

5.  Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

Authors:  Bernard Vrijens; Gäbor Vincze; Paulus Kristanto; John Urquhart; Michel Burnier
Journal:  BMJ       Date:  2008-05-14

Review 6.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

7.  A practice-based randomized controlled trial to improve medication adherence among Latinos with hypertension: study protocol for a randomized controlled trial.

Authors:  Antoinette Schoenthaler; Franzenith De La Calle; Miguel Barrios-Barrios; Aury Garcia; Maria Pitaro; Audrey Lum; Milagros Rosal
Journal:  Trials       Date:  2015-07-02       Impact factor: 2.279

8.  Racial/Ethnic disparities in the awareness, treatment, and control of hypertension - United States, 2003-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-05-10       Impact factor: 17.586

Review 9.  Epidemiology and management of hypertension in the Hispanic population: a review of the available literature.

Authors:  Nicolas J Guzman
Journal:  Am J Cardiovasc Drugs       Date:  2012-06-01       Impact factor: 3.571

10.  Predictive validity of a medication adherence measure in an outpatient setting.

Authors:  Donald E Morisky; Alfonso Ang; Marie Krousel-Wood; Harry J Ward
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 2.885

View more
  1 in total

Review 1.  Rapid review: Identification of digital health interventions in atherosclerotic-related cardiovascular disease populations to address racial, ethnic, and socioeconomic health disparities.

Authors:  Kelly J Thomas Craig; Nicole Fusco; Kristina Lindsley; Jane L Snowdon; Van C Willis; Yull E Arriaga; Irene Dankwa-Mullan
Journal:  Cardiovasc Digit Health J       Date:  2020-11-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.